T
Tim Magnus
Researcher at University of Hamburg
Publications - 154
Citations - 7001
Tim Magnus is an academic researcher from University of Hamburg. The author has contributed to research in topics: Microglia & Inflammation. The author has an hindex of 38, co-authored 133 publications receiving 5338 citations. Previous affiliations of Tim Magnus include Hamburg University of Technology & Eppendorf (Germany).
Papers
More filters
Journal ArticleDOI
Blockade of P2X7 receptors or pannexin-1 channels similarly attenuates postischemic damage
Abraham Cisneros-Mejorado,Miroslav Gottlieb,Fabio Cavaliere,Tim Magnus,Friederich Koch-Nolte,Eliana Scemes,Alberto Pérez-Samartín,Carlos Matute +7 more
TL;DR: Results show that P2X7 receptors and pannexin-1 channels are major mediators of postanoxic depolarization in neurons and of brain damage after ischemia, and that they operate in the same deleterious signaling cascade leading to neuronal and tissue demise.
Journal ArticleDOI
Targeting TNF-α receptors for neurotherapeutics
Wayne Chadwick,Tim Magnus,Bronwen Martin,Aleksander Keselman,Mark P. Mattson,Stuart Maudsley +5 more
TL;DR: This research was supported by the Intramural Research Program of the NIH, National Institute on Aging and the authors have no conflicts of scientific interest with respect to the manuscript.
Journal ArticleDOI
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.
TL;DR: The role of neuroinflammation in ischemic stroke pathology is critically discussed, focusing on the BBB and the interactions between central nervous system and peripheral immune responses, and the possibility of clinical implementation of imaging modalities to assess stroke-associated neuro inflammation with the potential to provide image-guided diagnosis and treatment.
Journal ArticleDOI
PI3Kδ inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model
Pei Ching Low,Silvia Manzanero,Nika Mohannak,Vinod K. Narayana,Tam H. Nguyen,David Kvaskoff,Faith H. Brennan,Marc J. Ruitenberg,Mathias Gelderblom,Tim Magnus,Helena H A Kim,Bradley Randal Scott Broughton,Christopher G. Sobey,Bart Vanhaesebroeck,Jennifer L. Stow,Thiruma V. Arumugam,Thiruma V. Arumugam,Frederic A. Meunier +17 more
TL;DR: In vivo, transient middle cerebral artery occlusion and reperfusion in kinase-dead PI3Kδ or wild-type mice pre- or post-treated with the PI3kδ inhibitor CAL-101, leads to reduced TNF levels, decreased leukocyte infiltration, reduced infarct size and improved functional outcome.
Journal ArticleDOI
CCR6 (CC Chemokine Receptor 6) Is Essential for the Migration of Detrimental Natural Interleukin-17-Producing γδ T Cells in Stroke.
Priyadharshini Arunachalam,Peter Ludewig,Patrick Melich,Thiruma V. Arumugam,Christian Gerloff,Immo Prinz,Tim Magnus,Mathias Gelderblom +7 more
TL;DR: It is demonstrated that therapeutic approaches targeting synergistic IL-17 and tumor necrosis factor-&agr; pathways in parallel offer additional neuroprotection in stroke, and brain-infiltrating IL-18–positive T cells belong to the subset of natural IL- 17–producing T cells.